Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Cancer|June 24, 2010
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphomaLuigi Rigacci, Alberto Fabbri, Benedetta Puccini, et al.
Transplant Immunology|September 18, 2022
Late haemophagocytic lymphohistiocytosis in a patient treated with Axicabtagene ciloleucelIlaria Cutini, Benedetta Puccini, Alberto Fabbri, et al.
European Journal of Haematology|May 10, 2023
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantroneEmanuele Cencini, Melania Rocco, Francesco Ghio, et al.
Hematological Oncology|November 20, 2012
Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-upAlberto Fabbri, Emanuele Cencini, Alice Pietrini, et al.
American Journal of Blood Research|September 14, 2020
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphomaEmanuele Cencini, Alberto Fabbri, Luana Schiattone, et al.
Hematology Reports|January 22, 2024
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life StudyEmanuele Cencini, Natale Calomino, Marta Franceschini, et al.
Virchows Archiv : an International Journal of Pathology|July 19, 2006
Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two casesIoannis Kostopoulos, Mario Cocco, Chiara Ginanneschi, et al.
Cancers|January 28, 2026
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective AnalysisSabrina Pelliccia, Marta Banchi, Lucrezia De Marchi, et al.
Leukemia & Lymphoma|October 11, 2017
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphomaEmanuele Cencini, Benedetta Puccini, Luigi Rigacci, et al.
Frontiers in Oncology|January 8, 2021
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma PatientsAlessandro Gozzetti, Francesca Bacchiarri, Vincenzo Sammartano, et al.
Pageof 9